There’s a once-in-a-lifetime shift happening in China right now.
And it could make early investors a lot of money…
Right now, the Chinese government provides some form of health insurance to almost all of its 1.4 billion citizens.
But public healthcare is a mess. There are simply too many patients for the poorly paid public doctors to care for. As a result, lines are long, and standards of care are poor for most Chinese citizens.
Distrust and frustration often boil over to the point where people humiliate or attack medical personnel when they feel their loved ones have been mistreated or neglected. For the typical Chinese citizen, a trip to a public hospital is unpleasant at best, and a nightmare at worst…
However, the Chinse healthcare system is rapidly changing.
You see, the Chinese middle class is quickly growing. In 2000, just four percent of China’s urban population was considered middle class. By 2022, that figure will be a whopping 76 percent. This is pushing up consuming spending. It’s set to increase 55 percent between 2015 and 2020.
With more money, the middle class is demanding better healthcare.
McKinsey & Company estimates that driven by the middle class, private healthcare spending in China will grow to $1 trillion by 2020, up from just over $350 billion in 2011.
The Chinese government is keenly aware of the frustrations of its citizens. So in 2011, the government took the first steps to allow private ownership of hospitals.
As a result, 2015 marked the first time that the number of private hospitals accounted for over half of the whole market. Still, the volume of services delivered by these small, private providers only accounted for 15 percent of the total amount of services provided to Chinese families. So there’s tons of room for growth.
This is a massive opportunity for companies that manage and own private hospitals in China.
And Stansberry Churchouse has found one company set to soar from this shift. It’s the largest private hospital management group in China – running a network of 104 hospitals and around 12,000 beds.
And it’s the only company of its kind in China that has the experience and expertise of managing large private hospitals.
Plus, with the Chinese government pushing hard for more private sector involvement in its ailing healthcare system, this company has a strong tailwind behind it.
The stock could easily double within 12 months and soar multiples higher over the next several years.
And it’s easy to buy this stock. You’ll likely be able to buy it from the brokerage account you already have with just a few clicks.
If you want to find out more about profiting from the coming Chinese consumer boom – including how to learn the name of this stock click here.